PTAB Upholds Patent In A First For Post-Grant Reviews
The Patent Trial and Appeal Board ruled Monday that Altaire Pharmaceuticals Inc. failed to prove a Paragon BioTeck Inc. eye solution patent was invalid, the first time the board has upheld...To view the full article, register now.
Already a subscriber? Click here to view full article